Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in
D

Dr. Neil LoveUnclaimed

Host of Hematologic Oncology Update.

1PodCred credit

1 Feed-stated

Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record

  • Host

Claim this profile+ Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.

This is not me · Request removal

+ FollowConnectMessage

This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.

About this profile

Profile
Unclaimed
Shows now
1

PodCred record

PodCred is the verified record of where Dr. has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.

Worked with Dr. on a show? This is where you give them credit.

+ Add a credit

Shows they work on now

1 show

  • Hematologic Oncology Update
    Host Feed-stated

Is an appearance missing?

People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.

No account needed. Anyone can give a credit.

Add an appearanceHow PodCred works

Experience, education, skills, and recommendations start empty. They fill in when Dr. claims this profile.

Recommendations

ReceivedGiven

No recommendations for Dr. yet.

Recommendations open once Dr. claims the profile.

Posts

No posts yet. Posts Dr. shares on PodSubs, and what Dr. publishes on Substack, YouTube and elsewhere, will show here.

Recent episodes

From the shows they work on now

10 episodes
  • Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on The Utility of Tafasitamab

    Hematologic Oncology Update

    Nov 16, 202616 minAudio

    Featuring an interview with Dr Matthew Lunning, including the following topics: Tafasitamab for follicular lymphoma (0:00) frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma...

  • Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies

    Hematologic Oncology Update

    Nov 14, 202658 minAudio

    Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics: Introduction (0:00) Prologue: Saturday Night Fever (1:35) Baby Boomers' Guide to Mechanisms of Action (3:07) Second-Line...

  • Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

    Hematologic Oncology Update

    Nov 11, 20261 hr 2 minAudio

    Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics: Multiple Myeloma (0:00) Introduction: ESMO 2026; Recent FDA Approvals (1:53) Chimeric Antigen Receptor T-Cell Therapy...

  • Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 2: An Interview with Dr Matthew Lunning on Novel Combination Regimens

    Hematologic Oncology Update

    Nov 6, 202618 minAudio

    Featuring an interview with Dr Matthew Lunning, including the following topics: Bispecific antibody/antibody-drug conjugate combinations (0:00) A man in his late 90s with mantle cell lymphoma - Ann LaCasce, MD, MMSc...

  • Diffuse Large B-Cell Lymphoma — A Grand Rounds Program

    Hematologic Oncology Update

    Nov 4, 20261 hr 2 minAudio

    Featuring a presentation by Dr Matthew Matasar, including the following topics: Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00) Clinician Survey Results Regarding...

  • Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 1: An Interview with Dr Matthew Lunning on CNS Prophylaxis

    Hematologic Oncology Update

    Nov 2, 202618 minAudio

    Featuring an interview with Dr Matthew Lunning, including the following topics: A woman in her late 70s with non-GCB diffuse large B-cell lymphoma receives pola-R-CHP - Ann LaCasce, MD, MMSc (0:00) CNS prophylaxis in...

  • Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6

    Hematologic Oncology Update

    Oct 28, 202633 minAudio

    Featuring perspectives from Dr Lindsey Roeker, including the following topics: Case: A man in his mid 60s with TP53-aberrant chronic lymphocytic leukemia (CLL) with extensive marrow infiltration receives first-line...

  • Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 5

    Hematologic Oncology Update

    Oct 28, 202626 minAudio

    Featuring perspectives from Dr Lindsey Roeker, including the following topics: Consensus Approach to optimizing front-line treatment (0:00) Emerging role of sonrotoclax (8:39) Bruton tyrosine kinase inhibitor...

  • Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome

    Hematologic Oncology Update

    Oct 21, 20261 hr 58 minAudio

    Featuring perspectives from Dr Spencer Bachow, Dr Bhavana (Tina) Bhatnagar, Dr Jennifer Crombie, Dr Manali Kamdar and Ms Alexandra Lynch, co-moderated by Dr Bachow and Dr Bhatnagar, including the following topics:...

  • Chronic Lymphocytic Leukemia — Microlearning Activity 2

    Hematologic Oncology Update

    Oct 16, 202628 minAudio

    Featuring perspectives from Dr Catherine C Coombs, including the following topics: Phase III BRUIN CLL-322 trial of fixed-duration pirtobrutinib in combination with venetoclax and rituximab for previously treated...

Showing 5 of 10
Report this profile